Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR445399 in Non-Cystic Fibrosis Bronchiectasis
NCT07547436Phase 2Suspended
- Sponsor
- Sanofi
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Modality
- Nanobodies (VHH)
- Countries
- 1
01
Overview
A Phase 2 trial of SAR445399 in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Sanofi. Started Jun 2026; status: suspended.
02
Drugs
SAR445399
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT07547436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07547436.